I completed my undergraduate degree in Molecular Biology and Genetics at McMaster University in Canada in 2022. Following this, I pursued a Master’s degree in Biochemistry and Biomedical Sciences, also at McMaster University, where I focused on elucidating the mechanisms of action of novel therapeutics targeting acute myeloid leukemia (AML).
In 2024, I joined the AG Saur lab as a Ph.D. researcher. My current work focuses on understanding the environmental factors which drive heterogeneity within pancreatic ductal adenocarcinoma (PDAC), with the aim of identifying and characterize the contributors to clonal evolution in PDAC tumors.
caylie.shull@tum.de